Results 61 to 70 of about 177,775 (151)

A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Immune checkpoint inhibitors have revolutionized treatment of advanced cutaneous melanoma. This group of novel therapeutic agents differs from other systemic treatments and has necessitated a new approach for several fundamental aspects of clinical ...
Oren Levine, Tahira Devji, Feng Xie
doaj   +1 more source

Pathomechanism of immune checkpoint inhibitors-induced cardiotoxicity

open access: yesMedycyna Paliatywna
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that work by blocking CTLA-4, PD-1 or PD-L1 molecules. They help activate the immune system to recognize and eliminate cancer cells. Immune checkpoint inhibitors are monoclonal antibodies that
Agata Kornacka   +5 more
doaj   +1 more source

Structural basis for the activity and specificity of the immune checkpoint inhibitor lirilumab

open access: yesScientific Reports
The clinical success of immune checkpoint inhibitors has underscored the key role of the immune system in controlling cancer. Current FDA-approved immune checkpoint inhibitors target the regulatory receptor pathways of cytotoxic T-cells to enhance their ...
Nicholas Lorig-Roach   +2 more
doaj   +1 more source

Nanomaterials and immune checkpoint inhibitors in cancer immunotherapy: the synergistic innovation prospects

open access: yesFrontiers in Immunology
Tumor cells can utilize the immune checkpoint pathway to inhibit T cell activation and evade the attack of tumor specific T cells. While immune checkpoint inhibitors (ICIs) competitively bind to checkpoint molecules to block checkpoint mediated ...
Jing Chen, Xue Cheng
doaj   +1 more source

Immune checkpoint inhibitor-related endocrinopathies

open access: yesJournal of Translational Internal Medicine, 2022
Lu, Difei, Gao, Ying
openaire   +2 more sources

Immune Checkpoint Inhibitors in Penile Cancer

open access: yesFuture Science OA, 2021
Carlo Buonerba   +9 more
openaire   +3 more sources

Immune checkpoint inhibitors for invasive mucinous adenocarcinoma: A case series. [PDF]

open access: yesOncol Lett
Kato T   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy